Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹204Cr
Rev Gr TTM
Revenue Growth TTM
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

SIKKO
VS
| Quarter | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | 14.0 | 25.3 | 42.9 |
| 13 | 12 | 10 | 20 | 15 | 15 | 14 |
Operating Profit Operating ProfitCr |
| 15.7 | 19.8 | 17.5 | -6.5 | 17.6 | 20.2 | 16.3 |
Other Income Other IncomeCr | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | 3 | 2 | -1 | 3 | 4 | 3 |
| 1 | 1 | 1 | 0 | 1 | 1 | 1 |
|
Growth YoY PAT Growth YoY% | | | | | 24.6 | 35.7 | 60.0 |
| 11.0 | 13.7 | 11.1 | -4.7 | 12.0 | 14.8 | 12.4 |
| 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Financial Year | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 0.8 | 18.0 |
| 57 | 55 | 64 |
Operating Profit Operating ProfitCr |
| 6.8 | 10.3 | 11.8 |
Other Income Other IncomeCr | 3 | 1 | 1 |
Interest Expense Interest ExpenseCr | 1 | 0 | 1 |
Depreciation DepreciationCr | 1 | 1 | 1 |
| 6 | 6 | 9 |
| 2 | 2 | 2 |
|
| | 5.0 | 46.0 |
| 6.6 | 6.9 | 8.6 |
| 2.4 | 0.1 | 0.1 |
| Financial Year | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 17 | 22 | 22 |
| 11 | 60 | 64 |
Current Liabilities Current LiabilitiesCr | 22 | 25 | 48 |
Non Current Liabilities Non Current LiabilitiesCr | 2 | 1 | 1 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 46 | 87 | 116 |
Non Current Assets Non Current AssetsCr | 5 | 21 | 19 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 2 | -31 |
Investing Cash Flow Investing Cash FlowCr | 1 | -16 |
Financing Cash Flow Financing Cash FlowCr | -3 | 47 |
|
Free Cash Flow Free Cash FlowCr | 4 | -41 |
| 51.8 | -729.6 |
CFO To EBITDA CFO To EBITDA% | 50.8 | -489.0 |
| Financial Year | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 114 | 163 |
Price To Earnings Price To Earnings | 27.9 | 38.3 |
Price To Sales Price To Sales | 1.9 | 2.6 |
Price To Book Price To Book | 4.1 | 2.0 |
| 28.8 | 26.2 |
Profitability Ratios Profitability Ratios |
| 27.4 | 32.9 |
| 6.8 | 10.3 |
| 6.6 | 6.9 |
| 20.3 | 7.5 |
| 14.6 | 5.2 |
| 7.9 | 4.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Established in **2000** and headquartered in **Ahmedabad, Gujarat**, Sikko Industries Limited (**NSE: SIKKO**) is a vertically integrated agrochemical company. Originally founded with a focus on agricultural machinery, the company has evolved into a comprehensive provider of crop protection, soil nutrition, and seed products. Following a strategic pivot in **October 2022**, SIL is currently diversifying its business interests into **pharmaceuticals, energy generation, and agricultural commodity trading**, aiming to transform from a specialized agro-player into a diversified industrial conglomerate.
---
### **Manufacturing Infrastructure & Strategic Expansion**
The company’s core operations are concentrated on the **Sanand-Viramgam Highway**, providing logistical advantages for both domestic distribution and raw material imports.
| Unit Type | Location | Key Products |
| :--- | :--- | :--- |
| **Pesticide Unit** | Sanand, Ahmedabad | Organic & Chemical Pesticides, Fungicides, Herbicides |
| **Fertilizer Unit** | Sanand, Ahmedabad | Organic & Chemical Fertilizers, Growth Promoters |
#### **Capacity Scaling & Capex**
To meet rising domestic demand and expand its "job-work" capabilities, SIL is executing a **₹41.25 crore** capital expenditure program.
* **Liquid Production:** Recently scaled from **28,000 KGS/Day** to **120,000 KGS/Day**.
* **Fertilizer Production:** Reached **450 MT/Day** (on a 2-shift basis).
* **Pesticide Powder Expansion:** Current capacity of **28,500 KGS/Day** is being expanded by **110,000 KGS/Day**, targeting a total post-expansion capacity of **138,500 KGS/Day**.
* **Land Acquisition:** In **June 2024**, the company approved the purchase of **16,723.50 Sq. Mtrs** of land at **Ajanta Industrial Estate, Sanand** from group company Siganjka Industries for **₹9.47 crore**.
#### **Sustainability & Utilities**
* **Energy:** Transitioning toward captive green energy with the installation of a **99.36 kW Grid-tie Solar PV rooftop system** to offset its **300KW** power requirement.
* **Water:** Consumption is maintained at a lean **2 KLD**, sourced via the Sanand Nagarpalika.
---
### **Diversified Product Portfolio & R&D Focus**
SIL operates a single reportable segment—the **Agro Chemical Business**—but maintains a highly diversified product mix designed to cover the entire crop lifecycle.
* **Agrochemicals:** A full suite of insecticides, fungicides, and weedicides. The company is specifically targeting the **herbicides** segment for high-growth potential.
* **Fertilizers & Nutrients:**
* **Traditional:** Urea, DAP, NPK complexes, and Ammonium Sulphate.
* **Specialty:** Water Soluble Fertilizers (**WSFs**) for fertigation and fortified fertilizers (Boron/Zinc) eligible for **NBS scheme** subsidies.
* **Nano-Technology:** Marketing of **Nano Urea** and **Nano DAP** for foliar application.
* **Growth Promoters:** Proprietary brands including **Vakil, Diamond, Vasool, and Biomono**.
* **Seeds & Equipment:** Production of organic seeds and a legacy line of manual and cylinder-based **agricultural sprayers**.
* **Research & Development:** An in-house R&D department (FY25 expenditure: **₹0.58 Lakhs**) focuses on **Integrated Nutrient Management**, soil health optimization, and cost-efficient formulations.
---
### **Market Reach and Distribution Strategy**
SIL utilizes a multi-channel marketing approach to maintain brand presence in a competitive landscape.
* **Distribution Network:** Over **400 reputed dealers** across India.
* **Key Domestic Markets:** Strongest presence in **Gujarat, Rajasthan, Maharashtra, Uttar Pradesh, and West Bengal**.
* **Export Growth:** SIL is a net exporter. Export sales rose from **₹76.44 Lakhs (FY24)** to **₹102.36 Lakhs (FY25)**, leveraging India’s **14% CAGR** in global agrochemical exports.
* **Farmer Engagement:** Direct-to-farmer marketing via "Rath Shows" (roadshows), field demonstrations, and the promotion of **Soil Health Cards** to encourage scientific fertilizer use.
---
### **Strategic Diversification: Pharma, Commodities, and Energy**
Under its updated **Memorandum of Association**, SIL is aggressively expanding beyond its agro-roots:
1. **Pharmaceuticals:** Plans to manufacture and trade **antibiotics, vaccines, nutraceuticals, and Ayurvedic products**.
2. **Agri-Commodities:** Entering the import/export and trading of **pulses, grains, spices, and processed foods**.
3. **Energy & Power:** In **March 2026**, the company proposed entering the renewable energy sector, focusing on **Solar, Wind, and Biomass gasification** for ammonia production, aligning with the **National Green Hydrogen Mission**.
---
### **Financial Structure and Capital Management**
The company has recently undergone significant capital restructuring to fund its expansion and improve stock market liquidity.
#### **Fundraising & Shareholding**
* **Rights Issue (January 2025):** Raised **₹49.39 crore** (oversubscribed by **115.25%**) at an issue price of **₹98.00 per share**.
* **Stock Split & Bonus (Late 2025):**
* Sub-division of **1** share (FV **₹10**) into **10** shares (FV **Re. 1**).
* **1:1 Bonus Issue** (allotment of **218,400,000** bonus shares).
* **Authorized Capital:** Increased from **₹17.50 crore** to **₹45 crore**.
#### **Debt Profile & Governance**
SIL maintains credit facilities with **ICICI Bank** and **HDFC Bank**, with a modified charge of **₹14.00 Crore** (Feb 2024) and other smaller asset-backed charges.
* **Director Remuneration (FY25):** Managing Director **Jayantibhai Kumbhani** and Chairman **Ghanshyambhai Kumbhani** each received **120.00 Lakhs**.
* **Subsidiaries:** Incorporated **Sikko Foundation** (Section 8 company) in **December 2024** for CSR and social initiatives.
---
### **Risk Profile and Mitigation**
Investors should consider the following risks inherent to SIL’s operations:
* **Legal & Regulatory:**
* **Insolvency Defense:** In **February 2026**, the **NCLT** dismissed a **₹6.56 crore** petition from Rosefinch Healthcare, ruling in SIL's favor.
* **Tax Litigation:** A **₹1.7 crore** Central Excise Duty demand is currently under appeal at **CESTAT**; the company has deposited **₹2.43 crore** under protest.
* **Operational Concentration:** All manufacturing is centralized in **Sanand**, making the company vulnerable to localized disruptions.
* **Environmental Compliance:** Handling hazardous materials like **yellow phosphorus** requires strict adherence to the **Insecticides Act, 1968**.
* **Market Volatility:** The business is highly seasonal (**Rabi/Kharif**) and sensitive to **Chinese overcapacity**, which has historically pressured margins.
* **Related Party Transactions:** Significant dealings with promoter-group entities like **Sikko Trade Link** and **Siganjka Industries** require ongoing monitoring for potential conflicts of interest.